Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Diabetes, Obesity & Metabolism|June 29, 2023
Diabetes remission in drug-naïve patients with type 2 diabetes after dorzagliatin treatment: A prospective cohort studyJiao'e Zeng, Shenglian Gan, Nianrong Mi, et al.
Journal of Food Protection|May 8, 2015
Development of Bioluminescent Cronobacter sakazakii ATCC 29544 in a Mouse ModelXiwen Wang, Zhiping Li, Xiaolin Dong, et al.
Analytical Chemistry|August 6, 2025
Quantitative HILIC-Q-TOF-MS Analysis of Glycosaminoglycans and Non-reducing End Carbohydrate Biomarkers via Glycan Reductive Isotopic LabelingAmrita Basu, Stephanie Archer-Hartmann, Pradeep Chopra, et al.
Metabolism: Clinical and Experimental|March 16, 2026
Once-weekly insulin GZR4 versus once-daily insulin degludec in Chinese people with type 2 diabetes: A multicenter, open-label, randomized, phase 2 trialLiming Chen, Xiaolin Dong, Qiumei Zhang, et al.
NEJM Evidence|June 7, 2026
HTD1801 in Combination with Metformin for Type 2 DiabetesLinong Ji, Zhifeng Cheng, Jianhua Ma, et al.
Pharmacological Research|August 7, 2024
Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimabYanyan Zhang, Zhaohui Pei, Beijian Chen, et al.
Scientific Reports|February 28, 2023
Residue-specific binding of Ni(II) ions influences the structure and aggregation of amyloid beta (Aβ) peptidesElina Berntsson, Faraz Vosough, Teodor Svantesson, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
A non-canonical EZH2/TRIM28 epigenetic axis drives heparan sulfate remodeling and melanoma metastasisNeil G Patel, Alexandra Drakaki, Farhan Valummel, et al.
Molecular Imaging and Biology|February 6, 2016
Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea PigsXiwen Wang, Zhiping Li, Bo Li, et al.
Diabetes, Obesity & Metabolism|April 15, 2024
Combination of retagliptin and henagliflozin as add-on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, active-controlled, phase 3 trialYao Wang, Chengxia Jiang, Xiaolin Dong, et al.
Pageof 9